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The evaluation of soft tissue tumors should be approached systematically, with careful
assessment of the patient’s age, clinical presentation, anatomical location of the mass,
and MRI characteristics. The imaging evaluation of a suspected soft tissue mass begins
with conventional radiography to exclude an underlying osseous lesion and assess for
any lesional calciﬁcation. MRI is particularly useful in evaluating the signal intensity,
enhancement pattern, and extent of soft tissue masses that can expand beyond fascial
planes and involve the neurovascular bundle, joint, or bone. Among the common benign
soft tissue tumors, a fairly deﬁnitive imaging diagnosis can be made in cases of lipoma,
elastoﬁbroma dorsi, hemangiomas, myositis ossiﬁcans, giant cell tumor of tendon
sheath, and peripheral nerve sheath tumors. In the remaining cases, the differential
diagnosis can be narrowed by knowing the patient’s demographics and any associated
syndromes, in conjunction with recognizing speciﬁc MRI features. Knowledge of the
World Health Organization’s tumor designations and the incidence of speciﬁc tumors
based on patient age and anatomical location are vital tools for the interpreting
radiologist.

The evaluation of soft tissue tumors should be approached
systematically, with careful assessment of the patient’s age,
clinical presentation, anatomical location of the mass, presence or absence of calciﬁcation, and MRI characteristics.1–3
The imaging evaluation of a suspected soft tissue mass begins
with conventional radiography, which serves to exclude an
underlying osseous lesion and evaluate for the presence or
absence of mineralization. MRI is particularly useful in evaluating the signal intensity, enhancement pattern, and extent
of soft tissue masses that can expand beyond fascial planes
and involve the neurovascular bundle, joint, or bone.1,4
MRI protocols for the evaluation of tumors must be
performed in at least two orthogonal planes and include
T1-weighted and T2-weighted sequences. Additional sequences to consider include gradient-echo imaging for the detection of hemorrhage, T1-weighted fat-suppressed images to
differentiate fat from hemorrhage, and enhanced imaging
after contrast administration.1–5 Several benign soft tissue
tumors can be diagnosed fairly deﬁnitively with imaging,
whereas the differential diagnosis of indeterminate lesion
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can be narrowed signiﬁcantly by combining knowledge of the
MRI signal characteristics and the incidence of speciﬁc tumors based on patient age and anatomical location.1,6,7
Although it is reassuring to know that benign soft tissue
lesions outnumber malignant tumors by a factor of 100:1,
masses deemed indeterminate by imaging criteria are often
referred for deﬁnitive biopsy.5 This imaging pictorial reviews
the more common benign soft tissue tumors of the musculoskeletal system among each of the histologic categories, as
outlined by the World Health Organization (WHO).8

Adipocytic Tumors
Adipocytic tumors represent the largest single group of
mesenchymal tumors, and benign subtypes include lipoma,
lipomatosis, lipomatosis of nerve, lipoblastoma/lipoblastomatosis, angiolipoma, myolipoma of soft tissue, chondroid
lipoma, spindle cell lipoma/pleomorphic lipoma, and hibernoma.9 Benign lipomatous lesions represent a vast array of
tumors that demonstrate a predominance of adipose signal
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Fig. 1 Intramuscular lipoma in brachialis. Axial T1-weighted image
shows a fatty mass (asterisk) in the brachialis that is isointense to
subcutaneous fat. Notice the ill-deﬁned margins (arrowheads) due to
the pliable fat inﬁltrating among the muscular ﬁbers.

on MRI; however, speciﬁc imaging features of various subtypes are beyond the scope of this article and may be
referenced more thoroughly in the literature.11–15 Furthermore, MRI may not always allow differentiation of benign and
malignant fatty tumors, but lesions >10 cm, thick septa, and
globular and/or nodular nonadipose areas should raise concern for liposarcoma.12
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Lipoma is the most common benign soft tissue tumor, is
composed of mature adipocytes, and most commonly
presents as a slow-growing palpable mass in middle-age
patients.10 Lipomas are often not imaged but follow fat on
all image sequences. It has been estimated that 70 to 90% of
adipocytic tumors have a diagnostic imaging appearance.1
Superﬁcial lipomas can blend imperceptibly with the surrounding subcutaneous fat, whereas intramuscular lipomas
can have ill-deﬁned margins due to fat inﬁltration among
muscle ﬁbers in deep-seated lesions (►Fig. 1). Intramuscular
lipomas occur most often in the thigh, shoulder, and upper
arm, and they are most common in men between the ages of
30 and 60.16
Lipomatosis (also known as Madelung disease) is a rare
diffuse overgrowth of mature adipocyte in the subcutis and
muscles that occurs in children <2 years of age or in adults.17
Diffuse lipomatosis usually involves the trunk but can involve
most of an extremity, head and neck, abdomen, and pelvis.17
When extremities are involved, the distal portions of the
forearms and legs are unaffected.16 It can also be associated
with macrodactyly, although there is no involvement of the
nerve as with neural ﬁbrolipoma.16 MRI demonstrates hyperintense T1-weighted fat within and between the involved
muscles and/or the subcutaneous tissues (►Fig. 2).18,19
The diagnosis of lipoblastoma and lipoblastomatosis
should always be high on the differential diagnosis list
when a fatty mass is identiﬁed in a young child. Lipoblastoma

Fig. 2 Lipomatosis of left arm. (a, b) Axial T1-weighted images of the left arm (a) and forearm (b) demonstrate marked subcutis and muscular
lipomatous inﬁltration (arrowheads) of the anterior compartment of the arm and extensor compartment of the forearm. No thickened septa or
nodular nonadipose components are present. (c) Clinical photograph shows diffuse enlargement of the left upper extremity.
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Fig. 3 Lipoblastoma of thigh of a 3-month-old boy. (a, b) Coronal (a) and axial (b) images through the right thigh show a well-circumscribed fatty
mass (arrowheads) in the posterior compartment with multiple septations, some of which are conﬂuent (arrow). No nodular nonadipose
components are present. (c) Resected specimen shows the corresponding well-circumscribed fatty mass that proved to be lipoblastoma.

and lipoblastomatosis refer to the circumscribed and diffuse
forms of the same tumor.16 Lipoblastoma is a localized tumor
composed of cells resembling fetal adipose tissue, and it is
most commonly detected as a palpable mass in a child <3
years of age, with boys affected two to three times more
frequently than girls.14–16 Lipoblastoma is a slow-growing,
well-circumscribed mass that most commonly involves the
extremities but can affect the mediastinum, retroperitoneum,
trunk, head, and neck.14 On MRI, lipoblastoma is a wellcircumscribed mass that is predominantly fatty, but nonlipomatous areas may have a nonspeciﬁc appearance and may
simulate liposarcoma.10 MR imaging of lipoblastoma has
been reported as relatively hypointense to subcutaneous fat
on T1-weighted imaging and containing thin septae. Lesions
may demonstrate cystic change and display variable enhancement patterns ranging from none, to mild, to marked
and heterogeneous (►Fig. 3).13,15 Lipoblastomatosis is the
corresponding unencapsulated diffuse process in which the
subcutis and underlying muscle of young children are invaded by these fatty masses.16

Fibroblastic/Myoblastic Tumors
The numerous benign ﬁbroblastic/myoﬁbroblastic tumors
include desmoid-type ﬁbromatosis, elastoﬁbroma, myositis
ossiﬁcans, myoﬁbroma and ﬁbro-osseous pseudotumor of
digits, nodular fasciitis, proliferative fasciitis, and ischemic
fasciitis, among others.20 For simpliﬁcation, the musculoskeletal ﬁbromatoses have been subdivided into superﬁcial (fascial) and deep (musculoaponeurotic) groups.20 The
superﬁcial ﬁbromatoses (palmar ﬁbromatosis, plantar ﬁbromatosis, juvenile aponeurotic ﬁbroma, and infantile digital
ﬁbromatosis) are small slow-growing tumors, whereas the
deep musculoskeletal tumors (infantile myoﬁbromatosis,
ﬁbromatosis colli, extra-abdominal desmoids tumor, and
aggressive infantile ﬁbromatosis) are typically large, rapidly
growing, and aggressive.20–22 Desmoid-type ﬁbromatosis is
an inﬁltrative clonal ﬁbroblastic proliferation that arises in
deep connective tissue in muscle, fascia, or aponeuroses of
patients between the teenage years and 40 years of age.22,23
Extra-abdominal ﬁbromatosis often involves the shoulder,
chest wall, back, thigh, head and neck, and knee.20,21 An

Fig. 4 Desmoid-type ﬁbromatosis of forearm in a 15-year-old boy. (a, b) Axial (a) and sagittal (b) fast spin-echo T1-weighted enhanced fatsuppressed images depict marked heterogeneous enhancement of the soft tissue masses (arrowheads) extending into the distal interosseous
space and lateral to the radius. No osseous erosion or invasion is identiﬁed.
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Fig. 5 Elastoﬁbroma about left inferior scapula. Axial T2-weighted
image shows classic location of elastoﬁbroma (arrowheads) about the
inferior pole of the scapula, deep to the serratus anterior muscle. The
elastoﬁbroma is primarily isointense relative to skeletal muscle, with
interlaced streaks of adipose tissue.

estimated 50 to 70% of ﬁbromatoses have a diagnostic imaging appearance on imaging; thus biopsy is usually required
except for lesions in the superﬁcial hands or feet.1 Desmoids
are homogeneously isointense to skeletal muscle on T1weighted images, heterogeneously hyperintense on T2weighted images, and demonstrate marked enhancement
of the noncollagenase components (►Fig. 4).24 Hypointense
bands likely correspond to dense conglomerations of collagen
bundles and do not enhance.25,26 MRI is particularly useful in
determining if lesions are single or multiple (multiple in 15%
of cases), delineating the extent of these inﬁltrative lesions,
depicting any neurovascular encasement, and evaluating for
response to treatment.20,27
Elastoﬁbroma dorsi is an ill-deﬁned slow-growing ﬁbroelastic tumorlike lesion classiﬁed by the WHO as a benign
ﬁbroblastic/myoﬁbroblastic tumor. Elastoﬁbroma likely rep-
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resents a response to repeated trauma or friction, most often
occurs in the soft tissues between the inferior scapula and
chest wall in up to 13 to 17% of elderly individuals (more
commonly in women), and is often bilateral.28–31 Less commonly, elastoﬁbroma may occur overlying the elbow or ischial
tuberosity, deltoid muscle, foot, or visceral locations.30 Although lesions are often incidentally detected during computed tomography (CT) of the chest performed for other
reasons, MRI can be performed for patients presenting with
growing, painful, or “snapping” periscapular masses, and MR
is typically diagnostic in cases of elastoﬁbroma dorsi. Lesions
typically demonstrate a mass at the inferior pole of the
scapula that is most often deep to the serratus anterior and
latissimus dorsi, and isointense relative to skeletal muscle
interlaced with streaks of adipose tissue (►Fig. 5).29,31
Myositis ossiﬁcans (MO) is subcategorized into posttraumatic and nontraumatic/pseudomalignant forms and myositis ossiﬁcans progressiva.32 Posttraumatic myositis ossiﬁcans
is the most common form (occurring in 75% of cases) and
usually seen more commonly in men in the second and third
decades.33 MO is a localized self-limiting reparative lesion
composed of reactive ﬁbrous tissue and bone) that can be the
result of a direct blow.32,34 Lesions most commonly affect the
vastus lateralis, brachialis, intercostals spaces, erector spinae,
pectoralis, gastrocnemius, and gluteal muscles.33 The three
phases of MO are the acute (pseudoinﬂammatory), subacute
(pseudotumoral), and chronic (self-limited) phases.35 CT is
the imaging modality of choice because it best demonstrates
the zonal pattern of calciﬁcation expected at the various
phases of development. CT demonstrates nonspeciﬁc soft
tissue swelling in the ﬁrst few weeks, but a characteristic
peripheral calciﬁed rim of variable thickness and central
isodensity develops after several weeks, and that rim becomes denser and more conﬂuent on subsequent imaging
(►Fig. 6).34 It is estimated that >95% of cases of MO have a
diagnostic imaging appearance on imaging.1
The MRI appearance of MO also depends on the stage of
maturation. The initial MRI ﬁndings of MO show striking

Fig. 6 Myositis ossiﬁcans in a 23-year-old man with an 8-week history of calf pain. (a) Axial fast spin-echo T2-weighted image of the right calf shows
edema-like signal changes (arrows) surrounding a heterogeneously hyperintense soft tissue mass (arrowheads) in the deep compartment of the
midcalf. (b) Corresponding nonenhanced computed tomography shows a peripherally calciﬁed mass (arrowheads), diagnostic of evolving
myositis ossiﬁcans. Mass was not biopsied, and patient was conservatively managed and followed.
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Fig. 7 Mature myositis ossiﬁcans. (a, b) Axial proton-density (a) and T2-weighted fat-suppressed (b) images through the right midthigh of a 17year-old girl with a 5-year history of thigh pain demonstrate a well-circumscribed mass (arrow) in the posterior compartment of the thigh with
hypointense margin and internal signal that is isointense to marrow. No associated edema-like signal changes are evident. (c) Lateral radiograph
conﬁrms mature heterotopic ossiﬁcation. Due to complaint of pain with resisted knee ﬂexion, patient was taken to surgery. (d) Photograph of the
resected specimen, which was conﬁrmed myositis ossiﬁcans.

heterogeneous edema-like signal changes within the enlarged muscle. Next, a masslike hyperintense T2-weighted
signal focus develops within the surrounding edema-like
signal changes during the ﬁrst days to 1 week after the
trauma (►Fig. 6). MRI often shows a well-deﬁned mass
with peripheral low signal within maturing MO, corresponding to peripheral mineralization (►Fig. 7).35 MO may be
confused with parosteal or soft tissue osteosarcoma; however, sarcomas develop over a longer period of time than MO
and typically do not have the intense surrounding edema-like
signal changes characteristic of the acute and subacute
phases.

mixed intermediate to low signal intensity soft tissue nodule,
low signal intensity on ﬂuid-sensitive sequences, and characteristic “blooming” (further signal loss) if gradient-echo
imaging is acquired (►Figs. 8 and 9). Lesions can be fairly
reliably differentiated from ﬁbroma of tendon sheath on MRI
because ﬁbroma will be intermediate to low signal intensity
on T2-weighted images and not “bloom” on gradient-echo
imaging.37 An estimated 70 to 90% of cases of GCTTS have a
diagnostic imaging appearance on imaging, and lesions are
often resected without biopsy.1

Fibrohistiocytic Tumors

Angioleiomyoma (also known as angiomyoma) and leiomyoma of deep soft tissue are the two benign smooth muscle
tumors.38 Angioleiomyoma is a small (<2 cm) vascular
smooth muscle tumor that arises from the tunica media of
veins or arteries. These tumors occur most often in women in
their fourth to sixth decades, and they present as painful,
slow-growing masses in which pain may be exacerbated by
cold, wind, pressure, pregnancy, or menses.39 MRI typically
demonstrates a well-deﬁned oval mass located superﬁcial to
the fascia with the most common sites the hand, ankle and
foot, and knee.39–41 In a series of 10 cases, angioleiomyoma
was solitary and most commonly isointense to muscle on T1-

Giant cell tumor of tendon sheath (GCTTS), diffuse-type GCT,
deep benign ﬁbrous histiocytoma, plexiform ﬁbrohistiocytic
tumor, and giant cell tumor of soft tissue are all benign
ﬁbrohistiocytic tumors.36 Of these lesions, GCTTS is the
most common. This is the focal form of pigmented villonodular synovitis, which presents in patients between 30 and
50 years of age, more commonly in women.36 GCTTS occurs
most often in the hand and ﬁngers along the synovium of the
tendon sheath or interphalangeal joint, followed by the wrist,
ankle/foot, and knee.36 T1-weighted imaging typically shows
Seminars in Musculoskeletal Radiology
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Fig. 8 Giant cell tumor of tendon sheath. (a, b) Axial proton density (a) and T1-weighted enhanced fat-suppressed (b) images show a wellcircumscribed nodule (arrows) extending along the ﬂexor tendon sheath of the third toe that is nearly isointense to skeletal muscle and markedly
enhances.

weighted images, heterogeneously hyperintense on ﬂuidsensitive sequences (with multiple linear or branching areas
of hyperintensity), and diffusely or heterogeneously
enhanced.42
Leiomyoma of deep soft tissue is exceptionally rare, with a
mean age of 25 years at presentation, occurring equally in

men and women.43 Whereas angioleiomyoma is conﬁned to
the subcutaneous or dermal regions, the leiomyoma of deep
soft tissue can arise in the deep somatic soft tissue (most
commonly the extremities), retroperitoneum, or abdominal
cavity.43 Tumors are well-circumscribed, frequently calciﬁed
masses, with “mulberry-like” or extensive calciﬁcation on

Fig. 9 Focal pigmented villonodular synovitis of posterior knee joint in a 41-year-old woman with knee pain. (a, b) Sagittal fast spin-echo protondensity (a) and T2-weighted fat-suppressed images delineate a well-circumscribed soft tissue nodule (arrows) located between the posterior joint
capsule and posterior cruciate ligament. Nodule is heterogeneously hyperintense on T2-weighted image, with foci of intermediate and low signal.
Patient was treated with open posterior excision and synovectomy. (c) Microscopic section shows admixture of histiocytoid cells, foamy cells,
lymphocytes, and giant cells (arrows) (hematoxylin and eosin).
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radiographs or CT.44 Reported MR imaging characteristics
include a well-circumscribed mass that is isointense to skeletal muscle on T1-weighted images, isointense to slightly
hyperintense on T2-weighted images, contains punctuate
signal voids corresponding to calciﬁcation, prominent vascular channels, and homogeneously enhanced (except for the
regions of calciﬁcation) due to their marked vascularity.44,45

presents as a solitary nonpainful mass in adults with a median
age of 60 years, more commonly in men.50 MR imaging
reports in the literature are sparse but report a well-deﬁned
mass that is isointense or hyperintense to skeletal muscle on
T1- and T2-weighted images, may contain central hemorrhagic necrosis, and either homogeneously or heterogeneously enhance.50,51

Pericytic (Vascular) Tumors

Vascular Tumors

Glomus tumor and myopericytoma are the two pericytic
tumors classiﬁed by the WHO.46 Glomus tumor is a rare
mesenchymal tumor that histologically resembles modiﬁed
smooth muscle cells of the glomus body. It occurs in both the
adult and pediatric population, with a mean tumor size of
1 cm.47 Patients almost always present with prolonged
history of focal and often debilitating pain, and most glomus
tumors occur in the distal hand (75%) or foot, especially in the
subungual region (65%).46,47 Glomus tumors are well-circumscribed nodules that are intermediate to skeletal muscle on
T1-weighted images, hyperintense on T2-weighted imaging,
and demonstrate marked homogeneous enhancement when
<1 cm. Larger lesions can be lobulated and demonstrate T2
heterogeneity and heterogeneous enhancement.47 Osseous
erosion is observed in 22 to 82% of nail bed glomus tumors.48

Vascular lesions have several different classiﬁcation systems,
depending on the perspective of the clinician, pathologist, or
radiologist. Benign nonaggressive vascular lesions are categorized by the WHO as hemangioma, epithelioid hemangioma, angiomatosis, and lymphangioma.52 Lesions are often
divided from the radiologist’s perspective into “low-ﬂow”
(lymphatic and venous malformations) and “high-ﬂow” (arteriovenous malformations) vascular malformations for diagnostic and therapeutic purposes.53 Hemangioma is one of the
most common soft tissue tumors, and it is subcategorized into
capillary, cavernous, venous, and arteriovenous varieties,
among others.54
Intramuscular hemangioma (angioma) is a deep hemangioma, in which there is a proliferation of benign vascular
channels within skeletal muscle associated with a variable
amount of fatty tissue.52 Lesions most commonly occur in
young adults and affect men and women equally. Most often
lesions involve the thigh, head and neck, arm, and trunk.54 An
estimated 90 to 95% of hemangiomas have an imaging
appearance that is diagnostic.1 Lesions are typically isointense or hypointense to muscle on T1-weighted imaging,
demonstrate areas of intralesional fat, and are heterogeneously hyperintense on T2-weighted images. Lesions often
contain tubular vessels primarily aligned in a parallel orientation and can contain signal voids corresponding to phleboliths (►Fig. 10).54
Venous hemangioma is composed of veins of variable size
and mainly presents in adults. Venous hemangiomas have

Skeletal Muscle Tumors
Rhabdomyoma is the only benign mesenchymal tumor with
skeletal muscle differentiation and much more rare than the
malignant counterpart, rhabdomyosarcoma, occurring in
<2% of all striated muscle tumors.39 Rhabdomyoma is categorized into either cardiac or extracardiac subtypes. The
cardiac subtype is associated with tuberous sclerosis, whereas the extracardiac subtype is very rare and not associated
with this syndrome.39,49 Extracardiac rhabdomyoma is classiﬁed as adult, fetal, or genital, and it has a predilection for the
head and neck. The adult type of rhabdomyoma typically

Fig. 10 Hemangioma of infraspinatus and teres minor muscles. (a) Sagittal T1-weighted image shows a heterogeneous soft tissue mass (asterisk)
throughout the infraspinatus and teres minor muscles with predominantly peripheral fatty replacement of the musculature (arrowheads). Fatty
muscular atrophy is secondary to vascular shunting by the hemangioma. (b) Sagittal T1-weighted fat-suppressed (FS) image obtained before
contrast administration depicts multiple hyperintense (arrowheads) and hypointense ovoid signal foci corresponding to thrombosed vessels seen
in cross section. (c) Axial T1-weighted enhanced FS image delineates the extent of the mass (arrowheads) that contains multiple enhancing
tubular structures primarily aligned in a parallel orientation.
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Fig. 11 Lymphangioma in a 16-year-old boy with aching shoulder. (a) Transverse sonograph obtained from posterior approach shows a
multiloculated macrocystic lesion that insinuates between the deltoid and triceps muscles (M) and the humerus (H). (b, c) Axial images show a
multiloculated cystic structure (arrowheads) in the quadrilateral space that is slightly hyperintense to muscle on T1-weighted sequence (a) and
markedly hyperintense on T2-weighted fat-suppressed image (b). Lesion was resected and proved to be lymphangioma.

large thick-walled veins that often thrombose and form
phleboliths. Arteriovenous hemangioma (malformation) is a
nonneoplastic vascular lesion with arteriovenous shunts that
can be either deep seated or cutaneous.52 Lesions demonstrate hypertrophied arteries and dilated venous spaces as
low-signal tubular structures on T1- and T2-weighted images.
Magnetic resonance angiography with contrast enhancement
can often better deﬁne the feeding arteries and draining
veins.55
Large vascular lesions with high degree of shunting can
lead to limb hypertrophy and heart failure. In addition, giant
cavernous hemangiomas can be complicated by thrombocytopenic purpura, in which the tumors sequester platelets,
leading to consumption coagulopathy (Kasabach-Merritt
syndrome).52,54,56 Multiple other syndromes involving hemangiomas exist including Maffucci syndrome, a rare mesodermal dysplasia in which multiple hemangiomas and
enchondromas are present. With Maffucci syndrome there

is a 20 to 30% incidence of malignant tumors developing
(mainly chondrosarcoma).57
Lymphangioma is a benign cavernous or cystic vascular
lesion composed of dilated lymphatic channels containing
watery or milky ﬂuid.58 Lesions are common in the pediatric
population, and most present at birth or during the ﬁrst years
of life with focal painless swelling.58,59 Cystic lymphangioma
most often involves the head and neck (48%), axilla, and groin;
the cavernous type also occurs in the upper trunk, extremities,
and abdomen.53,58 Lesions that contain cystic spaces >2 cm are
termed macrocystic lymphatic malformations, and those with
cystic foci <2 cm are termed microcystic.53 Lesions can rapidly
enlarge due to hemorrhage or infection.53 On sonography,
lymphangioma is evident as a cystic lesion with multiple
septations of varying thickness and occasional ﬂuid–ﬂuid
levels due to prior hemorrhage (►Fig. 11a).59 Macrocystic
lymphangioma characteristically presents as a heterogeneous
ﬂuid-ﬁlled mass on MRI that is isointense to muscle on

Fig. 12 Juxtacortical chondroma in a 19-year-old woman with intermittent knee pain. (a, b) Axial imaging of the distal femoral metadiaphysis
shows a well-circumscribed mass (arrow) abutting the femoral cortex that is hypointense to muscle on T1-weighted image (a) and hyperintense
with areas of low signal (arrowhead) on T2-weighted image (b). (c) Computed tomography–guided biopsy of the mass (arrowheads) from lateral
approach demonstrated this to be a periosteal chondroma. Note the internal mineralization (arrows), most marked along the posterior aspect of
the mass. Intralesional excision was subsequently performed.
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Fig. 13 Intramuscular myxoma of right thigh in a 53-year-old woman. (a, b) Coronal images through the thigh demonstrate an ovoid soft tissue
mass (asterisk) that is hypointense to skeletal muscle on T1-weighted image (a) and markedly hyperintense on fast spin-echo T2-weighted fatsuppressed (FS) image (b). Myxoma lacks a true capsule, and a classic MR imaging feature of myxoma is irregular hyperintense signal (arrow)
extending adjacent to the mass, due to inﬁltration of the tumor into the adjacent atrophic and edematous striated muscle. (c) Axial T1-weighted
enhanced FS image shows the typical heterogeneous septal enhancement throughout the myxoma (arrow). (d) The myxoma was marginally
resected, and gross specimen photograph shows a gelatinous mass with internal septae (asterisk).

T1-weighted imaging and hyperintense to fat on T2-weighted
imaging. Lesions lack a feeding vessel, do not enhance,
and insinuate between tissue planes (►Fig. 11b, c).39,53,60
Microcystic lesions may be intermediate in signal intensity
on both T1- and T2-weighted images.53

Chondro-Osseous Tumors
Soft tissue chondroma is the only benign chondro-osseous
tumor classiﬁed by the WHO (►Fig. 11). Chondromas are
painless tumors composed predominantly of hyaline cartilage that occur in extraosseous and extrasynovial locations.61,62 Nodules are almost always <3 cm, and most of
the tumors occur in the ﬁngers; however, lesions may also
occur in the hands, toes, feet, trunk and head, and neck.61,62
Mineralization is invariably demonstrated on radiographs or
CT, and masses are well circumscribed and approximate
hyaline cartilage on all MRI sequences, except for signal voids
at the site of mineralization (►Fig. 12).63
Seminars in Musculoskeletal Radiology

Vol. 17

No. 2/2013

Tumors of Uncertain Differentiation
Benign tumors of uncertain differentiation include lesions
such as intramuscular myxoma and juxta-articular myxoma.64 Intramuscular myxoma is a benign mesenchymal tumor characterized by abundant myxoid matrix, a small
number of spindle-shaped cells, and a poorly developed
vascular pattern.65 Myxoma typically present as a painless
palpable mass in the large muscles of the thigh, shoulder,
buttocks, and upper arm in patients 40 to 70 years of age,
more often in women.65–67 Tumors are most often solitary but
may be multiple or coincide with ﬁbrous dysplasia (Mazabraud syndrome).
On MRI, intramuscular myxoma is homogeneously low in
signal intensity on T1-weighted MR sequences (►Fig. 13a),
high signal intensity on T2-weighted or ﬂuid-sensitive MR
sequences (►Fig. 13b), and can have variable enhancement,
most typically intense and heterogeneous (►Fig. 13c).66–68
Myxoma commonly has well-deﬁned borders on MRI, although borders may be partially ill deﬁned due to lack of a

Downloaded by: Harriet F. Ginsburg Health Sciences Library. Copyrighted material.

164

true capsule and inﬁltration of the tumor into the adjacent
atrophic and edematous striated muscle.66–68 A peritumoral
fat rind can be present in 65% of cases, and increased signal in
the adjacent muscle on ﬂuid-sensitive sequences has been
shown in 55%.66 On gross examination, tumors are ovoid or
globular and have a glistening gray-white or white appearance with stringy gelatinous contents with occasional small
ﬂuid-ﬁlled cystlike spaces (►Fig. 12d).65 Local excision is
curative.
Juxta-articular myxoma is rare and predominantly occurs
around the knee. On MRI, this lesion is hypointense to skeletal
muscle, hyperintense on T2-weighted imaging, and may
involve the periarticular tendons, ligaments, joint capsule,
muscles, and subcutaneous tissues.69 Lesions may be differentiated from ganglia due to their ﬁne internal structures and
enhancement after contrast administration.69

Neural Tumors
Although neural tumors are classiﬁed by the WHO under
lesions of the nervous system, benign peripheral nerve sheath
tumors are presented here because they are often included
within the musculoskeletal and spine MRI examination ﬁeld of
view. Benign peripheral nerve sheath tumors are composed of
neurilemoma (schwannoma) and neuroﬁbroma, both of which
contain cells closely related to the normal Schwann cell.70
Neurilemoma is most often detected in patients between 20
and 50 years of age and represents 5% of all benign soft tissue
tumors. Neurilemomas most commonly occur in the cutaneous
tissues of the head and neck, ﬂexor surfaces of the extremities,
posterior mediastinum, and retroperitoneum.70 The neurilemoma is separable from the involved nerve, and surgical
resection is curative. Neurilemomas are solitary in the vast
majority of cases but are plexiform or multiple in 5% of cases.
Lesions occur with neuroﬁbromatosis type 2 in 3% of cases.70
Neuroﬁbroma is most often detected in patients 20 to
30 years old and comprises >5% of all benign soft tissue
tumors.70,71 The localized type of neuroﬁbroma occurs in 90%
of cases, with diffuse and plexiform types occurring less
commonly. Neurilemoma and neuroﬁbroma are difﬁcult to
differentiate on MRI, although some distinctive imaging
features have been described. In fact, an estimated 70 to
90% of peripheral nerve sheath tumors have a diagnostic
imaging appearance on MRI.1 Both lesions can have a fusiform
shape, although neurilemoma is more eccentric, and neuroﬁbroma is centrally positioned relative to the nerve. Neurilemoma tends to be more heterogenous due to relative
increases in the number of cystic cavitations, calciﬁcations,
and areas of central necrosis.72,73 Characteristic MR ﬁndings
of the localized neuroﬁbroma include low signal intensity on
T1-weighted images, high signal intensity on T2-weighted
imaging (►Fig. 14), and strong enhancement. Neuroﬁbromas
typically depict heterogeneously hyperintense signal on T2weighted imaging, with low signal areas corresponding to
ﬁbrous and collagenous regions, and high signal areas corresponding to myxomatous stroma and cystic degeneration.
Both tumors can exhibit the “split-fat” and “target” signs.
The “target sign” has been demonstrated in 58% of neuro-
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Fig. 14 Multiple neuroﬁbromas in patient with neuroﬁbromatosis.
Axial fast spin-echo T2-weighted image through the lumbar spine
shows multiple localized neuroﬁbromas throughout the lumbar spine
nerve roots, retroperitoneum, and paraspinal and psoas muscles. The
“target sign” is evident in multiple tumors, with hypointense central
collagenous/ﬁbrotic component (asterisk) and peripheral myxomatous stroma (arrowheads).

ﬁbromas and 15% of neurilemomas on MRI, and it refers to
the hypointense central area on T2-weighted imaging corresponding to ﬁbrosis, with a more hyperintense myxomatous stroma in the margins of the tumor.73 The “fat-split sign”
is a peripheral brim of fat surrounding the lesion on T1weighted imaging, corresponding to preservation of the
normal fat around the neurovascular bundle.73 Differentiating benign from malignant peripheral nerve sheath tumors
(MPNSTs) on MRI is sometimes difﬁcult, but worrisome
features include large size (10 cm on average for MPNSTs
versus 5 cm for neuroﬁbroma), peripheral enhancement,
perilesional edema-like signal changes, and intratumoral
cystic lesions.74

Conclusion
The vast majority of soft tissue tumors are benign and with a
fairly deﬁnitive imaging diagnosis typically made in cases of
lipoma, elastoﬁbroma dorsi, hemangiomas, MO, and giant cell
tumor of tendon sheath. In the remaining cases, the differential diagnosis can be narrowed by systematically assessing the
patient’s age, anatomical location of the mass, clinical presentation, and any associated syndromes. It is very helpful to
be aware of the WHO’s tumor designations and to be familiar
with the incidence of speciﬁc tumors based on patient age,
anatomical location, and characteristic MRI features.
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